Analysis of heritable mutations at the molecular and organismal levels can provide significant insights into the structural and functional composition of the mammalian genome. Certain types of mutations, namely, chromosomal deletions, translocations, and insertion-induced mutations, provide useful experimental reagents for accessing, at the molecular level, particular chromosomal segments or loci associated with specific developmental phenotypes.
In humans, chromosomal deletions have proved especially useful in the selection of DNA clones that map to genomic subregions associated, for example, with muscular dystrophy (1) (2) (3) , chronic granulomatous disease (4) , retinoblastoma (5, 6) , and sex determination (7) . In the mouse, analysis of complexes of radiation-induced deletion mutations has facilitated the development of gross functional maps of segments of the genome (8) (9) (10) (11) and is currently providing reagents for the development of fine-structure "point" mutation maps (12) as well as for more detailed molecular maps. Consequently, the exploitation of germ-line deletion mutations has great potential for expanding our understanding of the functional and physical composition of the mouse genome. However, most of the extant heritable deletion mutations of the mouse have arisen over a period of decades in radiationmutagenesis experiments and are limited to genomic regions including and surrounding recessive marker loci employed in the mouse visible specific locus test (13, 14) and a few dominant marker loci (15) (16) (17) . Therefore, currently available deletions cover only a small percentage of the genome.
The chemotherapeutic agent chlorambucil (CHL) can induce, in certain germ-cell stages of male mice, heritable specific locus mutations at frequencies perhaps as high as 1.3 X 10-3 mutations per locus per gamete (18) . The highest frequency of mutations is transmitted by sperm derived from CHL-exposed early spermatids-i.e., in progeny sired during the third week after CHL injection. Some of the mutations recovered from these and other post-spermatogonial germcell stages displayed genetic attributes usually associated with chromosomal deletions and translocations (18) . For example, a variant was recovered that was simultaneously mutant in d (dilute) and se (short ear), which are two closely linked [0.16 centimorgan (cM)] loci, suggesting a deletion event. Further, several lethal mutations were also identified that, on the basis of earlier findings (8, 9, 19) , could be assumed to carry deletions of the marker locus along with neighboring essential loci. Semisterility (low litter size) was observed in several mutant lines, which is often indicative of the segregation of a balanced translocation (20) . Furthermore, direct cytogenetic analysis also detected a three-band deletion of chromosome 4 in G-banded chromosome preparations derived from a b (brown) locus mutant as well as a translocation in a c (albino) locus mutant line (18) .
If the majority of post-spermatogonially induced CHL mutations are indeed deletional in nature, this mutagenesis protocol should be a highly efficient method for producing germ-line deletion mutations in the mouse. We report here further genetic and cytogenetic analysis of the set of specific locus mutations that were recovered in the CHL-mutagenesis experiments (18) , and the initial molecular characterization of 10 of them (two c, three b, four d, and one d-se). Eight of these 10 mutations were derived from CHL-exposed postgonial germ-cell stages and two were derived from exposed stem-cell spermatogonia. We demonstrate that the 8 mutations induced in postgonial stages are deleted for molecular probes at, or closely linked to, the marker loci, thereby confirming that CHL treatment of post-stem-cell stages does indeed induce deletion mutations with high efficiency. We also provide evidence that, in these same germ-cell stages, CHL induces heritable reciprocal translocations.
MATERIALS AND METHODS
Mice. All mice were bred at Oak Ridge National Laboratory. Each mutation studied was recovered in the progeny of CHL-treated (101/Rl x C3Hf/Rl)F1 wild-type males that had been crossed to T-stock females of the genotype a/a; b/b; p cch /p cch; d se/d se; s/s (18 (18) , and subsequent crosses were made to generate homozygotes (m*/m*) from each mutation. In cases where m/m* is phenotypically distinguishable from m/m (e.g., cch/c* mutants) or where the T stock supplies a linked marker (e.g., d se/d* + mutants), appropriate heterozygotes to be mated for the production of homozygotes can be directly identified, and the absence of homozygotes among 30 or more of their classified offspring was taken as evidence of prenatal lethality. In other cases (s/s* or b/b* mutants), lines that could be either m/m or m*/m* were generated by outcrosses to wild type, followed by an additional outcross and backcross; when all of 12 such lines were viable, the mutation was provisionally classified as viable. [Assuming equal transmission of m* and m, the probability that all 12 lines would be m/m by chance is (0.5)12 or 2 x 10-4; this probability is, however, greater if transmission of m* is reduced.] Homozygous lethality/viability results are shown in Table 1 , along with the fertility status of animals heterozygous for the mutation.
Since production of a reduced number of offspring can be indicative of gross chromosomal rearrangement (death of chromosomally unbalanced segregants), mutants that produced low litter size were studied cytogenetically in Giemsabanded mitotic metaphase preparations from cultured kidney fibroblasts (28) . The results of this karyotypic analysis, which (Fig. 1A) . To determine whether the entire tyrosinase gene [which spans >70 kb (29)] had been deleted, carriers (cch/cOR8Q and cch/coR-sQ) of the two CHL-induced mutations were crossed to cch/C 112K, which carries a radiation-induced c mutation that deletes tyrosinase, the Emv-23 integration site, and Mod-2 (refs. 9 and 22; E.M.R., unpublished results). Southern blots of EcoRI-digested DNAs from ClI2K/COR8Q and cI2K/COR-15Q 14.5-day fetuses, along with +/+ (C3H and 101) and cch/Cch (T and St2A) spleen DNA controls, were probed with MTY811 and, as a positive control for hybridization, with the chromosome 9 clone p94.1. Fig. 1A demonstrates that both CHL-induced c mutations completely lack tyrosinase sequences but display the 2.3-kb chromosome 9 fragment. This blot was then stripped and rehybridized with the c-linked probe 23 .3 (along with p94.1). Fig. 1B demonstrates that both CHL-induced mutant c chromosomes are also deleted for the 3.7-kb EcoRI fragment detected by probe 23 (25, 30) . In wild-type DNA, clone pO.3, derived from the region of integration of 25) , recognizes a 9-kb EcoRI fragment; in d DNA, it recognizes an 18-kb fragment that represents the 9-kb wild-type fragment plus the 9-kb integrated Emv-3 provirus. Fig. 3A demonstrates that, of the five d-se region mutations that were analyzed, dOR-37Q and Df(d se)OR34Q were missing the 9-kb wild-type fragment (like the radiation-induced deletion mutation Df(d se)lJRl4SL [10] ), indicating that they are deleted for the pO.3 sequence. Three primary non-d-se region mutants (b/boR-21Q, b/boR-19Q, and b/bOR-10Q), used as controls, display heterozygosity for the two fragments (Fig. 3B) .
Additionally, we hybridized the blot in Fig. 3A (18) . For CHL-exposed stem-cell spermatogonia, the mutation yield was not significantly greater than in controls. We have tried to generate homozygotes for 14 of the 18 mutations; 9 of 11 tested post-stem-cell mutations proved to be homozygous lethal, indicating multilocus involvement (19 Genetic and molecular biological studies in organisms ranging from bacteriophage to humans have repeatedly demonstrated the experimental power of utilizing genomic rearrangements (and particularly deletions) for the analysis of the composition and function of whole chromosomal regions and of specific genes within particular segments of a genome. In the mouse system, the use of existing complexes of radiationinduced deletion mutations available for regions surrounding the marker loci of the visible specific locus test is facilitating the development of fine-structure physical and functional maps for regions of substantial size (8-11, 14, 19, 31) . Indeed, molecular access to a specific chromosomal region and quite often to a specific gene of unknown product within a region, can be achieved by the use of deletion mutations for the mapping of DNA clones. Moreover, large deletions can be used as reagents in additional rounds of mutagenesis experiments for selecting N-ethyl-N-nitrosourea-induced presumed intragenic mutations that can aid in refining a regional functional map (12) . They can also be used as reagents for simplifying the mapping of new genetic loci (especially those defined only by lethal mutations).
N-Ethyl-N-nitrosourea currently is the most effective known mutagen of mouse spermatogonial stem cells (32) , where it is thought to induce primarily small intragenic changes (19, 33, 34 
